Limited Genetic Susceptibility to Severe Graves' Ophthalmopathy: No Role for CTLA-4 But Evidence for an Environmental Etiology
- 1 September 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 10 (9) , 791-798
- https://doi.org/10.1089/thy.2000.10.791
Abstract
Graves' disease (GD) is an autoimmune thyroid disease (AITD) characterized by hyperthyroidism and by the occurrence of a distinctive ophthalmopathy (orbitopathy), which presents with varying degrees of severity. Graves' disease clusters in families but the importance of heredity in the pathogenesis of the associated ophthalmopathy is unclear. We have studied the family history of 114 consecutive, ethnically mixed patients with severe Graves' ophthalmopathy (GO). Patients were selected by unambiguous single ascertainment. Seventyseven percent of patients were female and 59% smoked. The mean age at onset of their GD was 43 years (range 17-78 years). Forty-one patients (36%) had a family history of AITD, defined as a first- and/or a second-degree relative affected with either Graves' disease (GD) or Hashimoto's thyroiditis (HT). The segregation ratio for AITD in nuclear families in our ascertained Graves' ophthalmopathy families was 0.07 (0.12 in Caucasians only). Hence, the higher prevalence of AITD among relatives of Graves' ophthalmopathy patients agreed with the known genetic predisposition to AITD and this predisposition was stronger in women than in men. However, only 3 of the 114 patients had a family history of severe Graves' ophthalmopathy (all second-degree relatives) and the segregation ratio for GO was 0. These data did not support a major role for familial factors in the development of severe Graves' ophthalmopathy distinct from Graves' disease itself. In addition, we tested 4 candidate genes, human leukocyte antigen (HLA), tumor necrosis factor-β (TNF-β), CTLA-4 and the thyrotropin receptor (TSHR), for association with Graves' ophthalmopathy. These were negative except for the HLA and CTLA-4 genes, which were found to be weakly associated with GO giving similar relative risk (RR) as in GD patients without ophthalmopathy. These data suggested that environmental factors, rather than major genes, were likely to predispose certain individuals with AITD to severe Graves' ophthalmopathy. Smoking remains one example of such potential external insults.Keywords
This publication has 24 references indexed in Scilit:
- CTLA-4 and HLA gene susceptibility to thyroidassociated orbitopathyThe Lancet, 1999
- Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathyThe Lancet, 1999
- A population‐based study of Graves' disease in Danish twinsClinical Endocrinology, 1998
- CTLA4 Gene Polymorphism Confers Susceptibility to Graves' Disease in JapaneseThyroid®, 1997
- The Immunogenetics of Autoimmune Diabetes and Autoimmune Thyroid DiseaseTrends in Endocrinology & Metabolism, 1997
- Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonanceJournal of Clinical Endocrinology & Metabolism, 1995
- Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within familiesJournal of Clinical Endocrinology & Metabolism, 1992
- Update Thyroid-Associated OphthalmopathyAutoimmunity, 1992
- Endocrine Ophthalmopathy: Current Ideas Concerning Etiology, Pathogenesis, and TreatmentEndocrine Reviews, 1984
- Thyroid antibodies: A study of first degree relativesClinical Genetics, 1972